Discover 45 paid clinical trials in Rapid City, South Dakota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 45
Active & Responsive
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
for
Ulcerative Colitis
Location: 47 recruiting locations
Sponsor: Takeda
Sex: All
Age: 18 - 65
Code: NCT06095128
Recruiting
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
for
Locally Advanced Hepatocellular Carcinoma,
Location: 9 recruiting locations
Sponsor: Academic and Community Cancer Research United
Sex: All
Age: 18+
Code: NCT05168163
Phase2, Recruiting
A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis
for
Atopic Dermatitis
Location: 19 recruiting locations
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06718101
Phase2, Recruiting
Together Overcoming Diabetes - Great Plains
for
Diabetes
Location: 1 recruiting location
Sponsor: Johns Hopkins Bloomberg School of Public Health
Sex: All
Age: 10+
Code: NCT06770673
Recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
for
Osteoarthritis
Location: 25 recruiting locations
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07153471
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Sex: Female
Age: 18+
Code: NCT07013968
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
for
Heart Failure With Preserved Ejection Fraction,
Location: 96 recruiting locations
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07037459
Phase3, Recruiting
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung